Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience

Aristotle Bamias; George Bozas; Nikolaos Antoniou; I. Poulias; Katsifotis Harilaos; Andreas Skolarikos; Dionysios Mitropoulos; Christos Alamanis; G. Alivizatos; Haralambos Deliveliotis; Meletios A Dimopoulos

doi:10.1016/j.eururo.2007.03.072

Back

Shared by

Meletios A Dimopoulos

Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience

Article 2007 en

Authors

AB
Aristotle Bamias
GB
George Bozas
NA
Nikolaos Antoniou

Related publications

Article2011

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: A single institution experience

Aristotelis Bamias, Alexandra Karadimou, Nikolaos Soupos, Maria Sotiropoulou, Flora Zagouri, Dimitrios Haidopoulos, Nikolaos Thomakos, Alexandros Rodolakis, A. Antsaklis, Meletios A Dimopoulos

Article2005

Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: Efficacy, safety, and clinical benefit assessment

Eleni Efstathiou, George Bozas, A. Kostakopoulos, Efstathios Kastritis, C. Deliveliotis, N. Antoniou, D. Skarlos, C. Papadimitriou, Meletios A Dimopoulos, Aristotelis Bamias

Article2006

Young Age Is Associated with Favorable Characteristics but Is Not an Independent Prognostic Factor in Patients with Epithelial Ovarian Cancer: A Single Institution Experience

George Bozas, Meletios A Dimopoulos, Efstathios Kastritis, Eleni Efstathiou, Vassiliki Koutsoukou, Alexandros Rodolakis, George Vlahos, Zannis Voulgaris, Theoharis Papageorgiou, Dimitra Gika, Christos Papadimitriou, Aristotle Bamias

Article2017

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

Sofia Karageorgopoulou, Ioannis D. Kostakis, Maria Gazouli, Sonia Markaki, Marios Papadimitriou, Evangelos Bournakis, Meletios A Dimopoulos, Christos Papadimitriou

Article2005

Late relapse of epithelial ovarian cancer: a single institution experience.

Aristotle Bamias, Eleni Efstathiou, Maria Vassilakopoulou, V. Koutsoukou, C. Papadimitriou, Alexandros Rodolakis, Dimitrios Mitsibounas, George Vlahos, Meletios A Dimopoulos

Prognostic and Predictive Factors in Patients with Androgen-Independent Prostate Cancer Treated with Docetaxel and Estramustine: A Single Institution Experience

Discussion(0)

Related publications

Prognostic factors for early-stage epithelial ovarian cancer, treated with adjuvant carboplatin/paclitaxel chemotherapy: A single institution experience

Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: Efficacy, safety, and clinical benefit assessment

Young Age Is Associated with Favorable Characteristics but Is Not an Independent Prognostic Factor in Patients with Epithelial Ovarian Cancer: A Single Institution Experience

Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.

Late relapse of epithelial ovarian cancer: a single institution experience.